Advertisement
BDX Notícias Forex
BD Recalls ChloraPrep Clear 1 ML Applicators
Medical technology company Becton, Dickinson and Co. or BD has recalled one lot of ChloraPrep Clear 1 mL Applicators citing potential fungal contamination, the U.S. Food and Drug Administration said. Under certain environmental conditions, the contamination allows the growth of Aspergillus penicillioides within the packaging.
RTTNews
|
22 dias atrás
Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update
While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for fiscal 2024, while trimming annual revenue outlook.
RTTNews
|
224 dias atrás
BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters
Medical technology company BD or Becton, Dickinson and Co. (BDX) announced Friday the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.
RTTNews
|
342 dias atrás
BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device
Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.
RTTNews
|
462 dias atrás
BD To Sell Surgical Instrumentation Platform To STERIS For $540 Mln
Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Tuesday that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS plc (STE) for $540 million.
RTTNews
|
632 dias atrás
Becton, Dickinson Boosts FY23 Outlook - Update
While reporting financial results for the second quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews
|
679 dias atrás
Becton, Dickinson Boosts FY23 Outlook - Update
While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews
|
770 dias atrás
Becton, Dickinson Guides FY23 Below Estimates; Boosts Dividend 4.6% - Update
While reporting financial results for the fourth quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) initiated its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews
|
854 dias atrás
